Consistent with the role of FBXO32 in heart failure, toxicity annotation in IPA showed that cardiac hypertrophy ranked number one in the mutant FBXO32 heart, followed by mitochondrial dysfunction (Fig. 1e). This evidence concerns the gene FBXO32 and cardiac hypertrophy.